Impact of standard of care for psychosis in Parkinson disease.
Thomsen
T R
TR
Panisset
M
M
Suchowersky
O
O
Goodridge
A
A
Mendis
T
T
Lang
A E
AE
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009462:Neurology / Q000592:standards*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D011618:Psychotic Disorders / Q000150:complications* / Q000628:therapy*; D011785:Quality Assurance, Health Care; D013997:Time Factors
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents